{"id":"W4319970241","doi":"10.3390/pharmaceutics15020601","title":"Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union","year":2023,"lang":"en","type":"review","venue":"Pharmaceutics","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Canada","funders":"Health Canada; Agencia Española de Medicamentos y Productos Sanitarios; World Health Organization","keywords":"Bioequivalence; European union; Tolerability; Excipient; Pharmacology; Pharmacodynamics; Generic drug; Drug; Clinical trial; Medicine; Equivalence (formal languages); Food and drug administration; Pharmacokinetics; Business; Mathematics; Adverse effect; Internal medicine; International trade","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0154241,0.0009591692,0.001935505,0.002294654,0.0008305625,0.002797391,0.003267091,0.006948677,0.005365219],"category_scores_gemma":[0.008253807,0.0006417239,0.002211557,0.001760277,0.001210519,0.002082983,0.00178763,0.004163181,0.003437409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001652992,"about_ca_system_score_gemma":0.008294053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003029206,"about_ca_topic_score_gemma":0.001857071,"domain_scores_codex":[0.9902637,0.002457159,0.0016508,0.0007873478,0.004196248,0.0006447585],"domain_scores_gemma":[0.9904107,0.003020443,0.001664687,0.0005820444,0.004024403,0.0002976843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003545384,0.0005701849,0.0003841579,0.02002381,0.0001027992,0.00118128,0.0004433766,0.001560233,0.02804418,0.07335927,0.06965681,0.8043194],"study_design_scores_gemma":[0.00006852987,0.0002845484,0.001183398,0.006240436,0.0001134335,0.000928583,0.00008257062,0.0002319129,0.005346244,0.003444148,0.9820461,0.00003011123],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007992461,0.7847384,0.02919644,0.01388361,0.003084598,0.001689767,0.001573898,0.0006913466,0.1571495],"genre_scores_gemma":[0.07872511,0.7339617,0.09090473,0.0301238,0.001616019,0.005660851,0.006340717,0.0003037255,0.05236337],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0154241,"threshold_uncertainty_score":0.0815714,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4280218919215843,"score_gpt":0.5174462811157179,"score_spread":0.08942438919413359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}